Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Obeticholic Acid (6-ECDCA) is a Farnesoid X Receptor Agonist. The mechanism of action of obeticholic acid is as a Farnesoid X Receptor Agonist.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 41.00 | |
10 mg | In stock | $ 48.00 | |
25 mg | In stock | $ 75.00 | |
50 mg | In stock | $ 101.00 | |
100 mg | In stock | $ 166.00 | |
200 mg | In stock | $ 288.00 | |
500 mg | In stock | $ 531.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 45.00 |
Description | Obeticholic Acid (6-ECDCA) is a Farnesoid X Receptor Agonist. The mechanism of action of obeticholic acid is as a Farnesoid X Receptor Agonist. |
Targets&IC50 | FXR:99 nM(EC50) |
Synonyms | INT-747, 6-Ethylchenodeoxycholic acid, 6-ECDCA |
Molecular Weight | 420.63 |
Formula | C26H44O4 |
CAS No. | 459789-99-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 78 mg/mL (185.4 mM)
Ethanol: 78 mg/mL (185.4 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Obeticholic Acid 459789-99-2 Autophagy Metabolism FXR INT-747 orally NR1H4 active farnesoid INT 747 receptor Inhibitor 6-Ethylchenodeoxycholic acid 6-ECDCA inhibit INT747 inhibitor